REQUEST A DEMO
Total
USD $0.00
Search more companies

Avicenna Farma N9 OOO (Russia)

Main Activities: Pharmacies and Drug Stores
Full name: Avicenna Farma N9 OOO Profile Updated: August 19, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

Avicenna Farma N9 OOO is an enterprise based in Russia. Its main office is in Moscow. The company operates in the Pharmacies and Drug Stores industry. The enterprise was incorporated on March 24, 2017. From the latest financial highlights, Avicenna Farma N9 OOO reported a net sales revenue drop of 4.37% in 2023. Over the same period, its total assets grew by 14.96%. In 2023, Avicenna Farma N9 OOO’s net profit margin increased by 2.95%.

Headquarters
Novoostapovskaya, 4, 1, 1, Pom. XXIII, Komn. 2-5
Moscow; Moscow; Postal Code: 115088

Contact Details: Purchase the Avicenna Farma N9 OOO report to view the information.

Basic Information
Outstanding Shares:
Purchase the Avicenna Farma N9 OOO report to view the information.
Registered Capital:
Purchase the Avicenna Farma N9 OOO report to view the information.
Incorporation Date:
March 24, 2017
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Avicenna Farma N9 OOO report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
-4.37%
Total operating revenue
-4.37%
Operating profit (EBIT)
-22.06%
Net Profit (Loss) for the Period
42.29%
Total assets
14.96%
Total equity
25.94%
Operating Profit Margin (ROS)
-1.61%
Net Profit Margin
2.95%
Return on Equity (ROE)
2.37%
Debt to Equity Ratio
-7.89%
Quick Ratio
0.16%
Cash Ratio
0.15%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?